Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Current Treatment Options in Cardiovascular Medicine
|
June 9, 2019
Cardiotoxicity of Immune Checkpoint Inhibitors
Lili Zhang, Maeve Jones-O'Connor, Magid Awadalla, et al.
The American Journal of Gastroenterology
|
April 22, 2005
Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes
Kevin A Waschke, Alexandra-Chloe Villani, Severine Vermeire, et al.
Iscience
|
November 13, 2023
Single-cell RNA sequencing of murine ankle joints over time reveals distinct transcriptional changes following <i>Borrelia burgdorferi</i> infection
Jennifer D Helble, Michael J Walsh, Julie E McCarthy, et al.
Pediatric Research
|
November 9, 2021
Single-cell immunophenotyping of the fetal immune response to maternal SARS-CoV-2 infection in late gestation
Juan D Matute, Benjamin Finander, David Pepin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2021
Altered ratio of dendritic cell subsets in skin-draining lymph nodes promotes Th2-driven contact hypersensitivity
Hannah L Miller, Prabhakar Sairam Andhey, Melissa K Swiecki, et al.
Journal of the American Heart Association
|
November 16, 2020
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis
Zsofia D Drobni, Amna Zafar, Leyre Zubiri, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events
Steven M Blum, Ben Ouyang, Leyre Zubiri, et al.
Kidney International Reports
|
October 26, 2020
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors
Harish Seethapathy, Sophia Zhao, Ian A Strohbehn, et al.
Journal for Immunotherapy of Cancer
|
July 3, 2021
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data
Kerry L Reynolds, Shaily Arora, Ravikumar Komandur Elayavilli, et al.
Nature
|
May 17, 2019
Targeting the CBM complex causes T<sub>reg</sub> cells to prime tumours for immune checkpoint therapy
Mauro Di Pilato, Edward Y Kim, Bruno L Cadilha, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Current Treatment Options in Cardiovascular Medicine
|
June 9, 2019
Cardiotoxicity of Immune Checkpoint Inhibitors
Lili Zhang, Maeve Jones-O'Connor, Magid Awadalla, et al.
The American Journal of Gastroenterology
|
April 22, 2005
Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes
Kevin A Waschke, Alexandra-Chloe Villani, Severine Vermeire, et al.
Iscience
|
November 13, 2023
Single-cell RNA sequencing of murine ankle joints over time reveals distinct transcriptional changes following <i>Borrelia burgdorferi</i> infection
Jennifer D Helble, Michael J Walsh, Julie E McCarthy, et al.
Pediatric Research
|
November 9, 2021
Single-cell immunophenotyping of the fetal immune response to maternal SARS-CoV-2 infection in late gestation
Juan D Matute, Benjamin Finander, David Pepin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2021
Altered ratio of dendritic cell subsets in skin-draining lymph nodes promotes Th2-driven contact hypersensitivity
Hannah L Miller, Prabhakar Sairam Andhey, Melissa K Swiecki, et al.
Journal of the American Heart Association
|
November 16, 2020
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis
Zsofia D Drobni, Amna Zafar, Leyre Zubiri, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events
Steven M Blum, Ben Ouyang, Leyre Zubiri, et al.
Kidney International Reports
|
October 26, 2020
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors
Harish Seethapathy, Sophia Zhao, Ian A Strohbehn, et al.
Journal for Immunotherapy of Cancer
|
July 3, 2021
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data
Kerry L Reynolds, Shaily Arora, Ravikumar Komandur Elayavilli, et al.
Nature
|
May 17, 2019
Targeting the CBM complex causes T<sub>reg</sub> cells to prime tumours for immune checkpoint therapy
Mauro Di Pilato, Edward Y Kim, Bruno L Cadilha, et al.
Page
of 3